What does PONV stand for?

Prevention of Nausea and Vomiting

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Profile of Nonverbal Sensitivity (social test) Program on Nonviolent Sanctions and Cultural Survival (Center for International Affairs at Harvard University) Personnel Of the Naval Shore Establishment (Report) Program On Non-collegiate Sponsored Instruction Parallel Optimization of New Technologies (postgenomic technology project) Pontiac Person Of No Tactical Importance Planning Of Non-specific Transportation by an Intelligent Fleet Expert Perceivable, Operable, Navigable, Understandable, Robust (web site design) Post-Operative Nausea and Vomiting		Pennsylvania, Ontario, New York (baseball league; now New York-Pennsylvania League) Piano Outreach of New York Prostitutes Of New York Protecting Our Nation's Youth Port of New York Authority (now Port Authority of New York and New Jersey) Point of Order Point of Origin Power of One (United States Power Squadrons) Price of Oil Priority Operational Objectives

Samples in periodicals archive:

5mg soft gelatine capsule oral formulation for the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy (MEC) in adults.

United States : Helsinn Group Palonosetron Receives EMA Approval

5 mg soft gelatine capsule oral formulation has been approved by the EMA (European Medicine Agency) for the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy (MEC) in adults.

Cancer Supportive Care: Oral Palonosetron Approved in EU

Ondansetron tablets are anti-emetics and are indicated for prevention of nausea and vomiting in patients undergoing chemotherapy, radiation therapy or surgery, it added.

Aurobindo Pharma gets USFDA nod for Ondansetron

Kytril (granisetron hydrochloride), marketed by SmithKline Beecham, is indicated for the prevention of nausea and vomiting associated with a broad range of initial and repeat courses of moderate and highly emetogenic chemotherapies.

Cancer patients find relief in new drugs

Rolapitant, the lead product, recently completed Phase II clinical testing for prevention of nausea and vomiting related to cancer chemotherapy and surgery, and other indications.

OPKO Health Acquires Lead NK-1 Compounds from Schering-Plough ...

5 mg soft gelatine capsule oral formulation has been approved by the EMA for the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy (MEC) in adults.

United States : Cancer Supportive Care: Oral Palonosetron Approved in ...

The ondansetron thin film formulation is a new oral formulation in development for the prevention of chemotherapy-induced nausea and vomiting, prevention of nausea and vomiting associated with radiotherapy, and post-operative nausea and vomiting.

MonoSol Rx Licenses Thin Film Formulation of Ondansetron to Strativa ...

Aloxi(R) obtained a centralized registration in Europe in 2005, with an indication for the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy, and the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.

Helsinn Healthcare SA Announces the Launch of Aloxi(R) (Palonosetron) ...